GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
IOL Chemicals & Pharmaceuticals Ltd

IOL Chemicals & Pharma: Board Meeting for FY26 Audited Financial Results

BOARD ● No Immediate Change LOW RISK
📅 Filed on BSE: 13 May 2026, 04:34 PM IST  ·  BSE ID: e3fe672c-0057-47c1-90c5-77b48201193b
View Original BSE Filing (PDF)
💡
In Simple Terms
The company will hold a board meeting on May 20, 2026, to approve its full-year financial results.
🤖 AI Summary
  • Board Meeting of IOL Chemicals & Pharmaceuticals scheduled for May 20, 2026.
  • Purpose: Consider and approve Audited Standalone and Consolidated Financial Results.
  • Period covered: Quarter and financial year ended March 31, 2026.
  • Trading window closed from April 1, 2026, to reopen on May 23, 2026.
  • Closure is pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
👥 What This Means For Shareholders
✅
Action Required
No action required from shareholders at this time.
👤
Who Is Affected
All shareholders are indirectly affected as the company prepares to disclose its financial performance for the quarter and financial year ended March 31, 2026.
🔍
Management Signal
The announcement indicates management's adherence to regulatory timelines for financial reporting and insider trading regulations.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Audited Standalone Financial Results for FY26 — released after May 20, 2026.
Audited Consolidated Financial Results for FY26 — released after May 20, 2026.
Trading window reopening — scheduled for May 23, 2026.
LOW RISK The filing is a routine procedural announcement with no inherent risks disclosed.
💡 Investor Takeaway
IOL Chemicals & Pharmaceuticals Ltd will hold a Board Meeting on May 20, 2026, to approve its Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026. The trading window will remain closed until May 23, 2026.
You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.